Frank M. Svoboda, Co-President and CEO of Globe Life Inc. (NYSE: ), recently sold a significant portion of its common stock. According to a filing with the Securities and Exchange Commission, Svoboda sold a total of 13,448 shares on January 6, 2025. The shares were sold at prices ranging from $112.2959 to $113.091 per share, for a total transaction value of approximately $1.51 million. The transaction comes as Globe Life trades at an attractive P/E ratio of 9.4x, with the company maintaining strong profitability as evidenced by net income of $1.1 billion over the last twelve months.
Additionally, Svoboda exercised stock options to acquire 16,000 shares at $87.60 per share, for a total of $1,401,600. Following these transactions, Svoboda directly holds 18,948 shares and indirectly holds 144,898 shares in a family trust and 1,931,401 shares in a Thrift/401(k) Plan Trust. The company has demonstrated strong shareholder commitment, maintaining dividend payments for 55 consecutive years with dividend growth of 6.7% in the last year. InvestingPro the analysis reveals 8 additional key insights about Globe Life’s financial health and market position.
These transactions reflect Svoboda’s ongoing management of his equity stake in Globe Life, a company known for offering life insurance that currently has an estimated market capitalization of $9.4 billion.
In other recent news, Globe Life Inc. experienced several significant developments. The company reported strong financial results in the third quarter of 2024, with net income rising to $303 million and net operating income increasing 29% to $308 million. Following these results, Truist Securities revised its 2024 and 2025 earnings per share estimates, which led to an increase in the target price to $105.00.
Globe Life also responded to a critical report by Viceroy Research, arguing that the claims were baseless and highlighting the successful transition to a virtual business model for its subsidiary, American Income Life (AIL). The company reported a 6.7% increase in revenue over the last twelve months, which was attributed to the expansion of AIL’s agent workforce and increased policy issuance.
Additionally, TD Cowen reaffirmed its confidence in Globe Life, maintaining a Buy rating and a $150.00 price target. This approval follows a positive outlook expressed by Globe Life’s management regarding ongoing regulatory investigations and the performance of the company’s core business.
The company has also implemented an executive severance plan that covers scenarios involving the termination of co-CEOs and other named executive officers, as detailed in a recent SEC 8-K filing. Furthermore, Globe Life expanded its share buyback program to $1.8 billion, highlighting its commitment to optimizing shareholder value. These are recent events surrounding Globe Life Inc.
This article was generated with the help of AI and reviewed by an editor. See our T&C for more information.
